Coya Therapeutics Inc (COYA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access COYA Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Coya Therapeutics Inc manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent43.18
Cash & Short-term Investments43.00
Prepaid Expense And Other Assets Current4.45
Total Current Assets47.06
Equipment/Property/Plant Net0.01
Other Assets, Noncurrent0.24
Total Assets47.31
Liabilities
Accounts Payable, Current AC1.09
Accrued Liabilities, Current AC1.19
Other Liabilities, Current0.00
Deferred Revenue, Current DE1.23
Total Current Liabilities3.51
Total Long-term Debt0.00
Other liabilities, Noncurrent0.52
Deferred Collaboration Revenue0.75
Total Liabilities4.03
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock119.08
Retained Earnings / Accumulated Deficit-75.81
Other Equity0.00
Common Stockholder's Equity43.28
Total Stockholder's Equity43.28
Liabilities & Stockholder's Equity47.31
4 historic quarters locked

Sign in to unlock the full Coya Therapeutics Inc balance sheet history.

About Coya Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-343481

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.